精华制药(002349) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was ¥324,309,670.10, a decrease of 15.43% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2023 was ¥40,741,923.16, an increase of 5.02% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥38,415,738.94, up 7.55% from the previous year[5] - Total operating revenue for Q3 2023 was CNY 1,119,659,192.47, a decrease of 4.8% compared to CNY 1,175,028,595.83 in the same period last year[18] - Net profit for Q3 2023 was CNY 220,131,018.03, representing an increase of 16.2% compared to CNY 189,378,012.57 in Q3 2022[20] - The total comprehensive income for the third quarter was CNY 220,131,018.03, an increase from CNY 189,378,012.57 in the previous year, representing a growth of approximately 16.2%[21] Assets and Liabilities - Total assets at the end of Q3 2023 reached ¥3,123,660,776.60, reflecting a growth of 2.70% compared to the end of the previous year[5] - The company's total assets increased to CNY 3,123,660,776.60, up from CNY 3,041,677,568.76 at the end of the previous quarter[17] - Total liabilities decreased to CNY 369,138,465.83, down from CNY 417,934,051.11 in the previous quarter[17] - The company's non-current liabilities due within one year decreased by 35.81% to CNY 436,130.61, primarily due to a reduction in lease liabilities from its subsidiary Dongli Management[10] - Other current liabilities fell by 57.50% to CNY 2,414,317.39, mainly due to a decrease in advance sales payments and related VAT output tax[10] Cash Flow - Cash received from operating activities decreased by 53.02% to CNY 35,300,492.62, primarily due to the inclusion of subsidiary Jin Silin Pharmaceutical in the consolidated financial statements and a reduction in government subsidies[11] - The net cash flow from operating activities was CNY 195,942,182.47, down from CNY 247,371,958.46, indicating a decrease of about 20.7% year-over-year[24] - The total cash outflow from operating activities was CNY 910,016,803.08, down from CNY 963,245,791.67, a decrease of about 5.5%[24] - The cash inflow from financing activities was CNY 16,000,000.00, a decrease from CNY 69,800,000.00, reflecting a decline of about 77.0%[24] Earnings and Shareholder Information - The company's basic earnings per share for Q3 2023 was ¥0.0500, an increase of 5.04% year-on-year[5] - Basic and diluted earnings per share for the quarter were both CNY 0.2399, up from CNY 0.2074, marking an increase of approximately 15.1%[21] - The total number of ordinary shareholders at the end of the reporting period was 143,120, with the largest shareholder, Nantong Industrial Holdings Group Co., Ltd., holding 34.39% of shares[12] Financial Position and Investments - The company reported a significant increase of 146.97% in trading financial assets, totaling ¥308,603,465.75 as of September 30, 2023[9] - The company experienced an 82.73% increase in notes receivable, amounting to ¥41,734,728.15[9] - Cash flow from investment activities saw a substantial decline of 69.26%, with cash recovered from investments dropping to CNY 155,900,000.00[10] - The net cash flow from investment activities was negative at CNY -198,053,599.96, a significant drop from CNY 15,542,442.47 in the prior year[24] Expenses and Income - Total operating costs decreased to CNY 864,866,529.85, down 8.3% from CNY 942,697,308.65 year-on-year[18] - Research and development expenses for Q3 2023 were CNY 44,544,568.46, a slight decrease from CNY 47,557,128.54 in Q3 2022[20] - Financial expenses decreased by 38.64% to CNY -19,539,774.32, attributed to increased interest income from deposits and reduced bank loan interest payments[10] - Other income dropped by 84.48% to CNY 2,386,702.42, mainly due to fewer government subsidies received compared to the previous year[10] - The company reported a financial income of CNY 18,416,709.43, an increase from CNY 11,324,426.38 in the same period last year[20] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[20] Audit Status - The company has not undergone an audit for the third quarter report[25]